Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heimann

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 6, 2014
Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in GermanyS M Heimann, M J G T Vehreschild, L Meintker, et al.
The Journal of Hospital Infection|November 14, 2018
Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016S M Heimann, M J G T Vehreschild, O A Cornely, et al.
Blood|August 3, 2006
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependentLuca Gattinoni, Anju Ranganathan, Deborah R Surman, et al.
European Journal of Haematology|October 15, 2014
A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantationSebastian M Heimann, Maria J G T Vehreschild, Oliver A Cornely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile InfectionVimalanand S Prabhu, Oliver A Cornely, Yoav Golan, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 10, 2010
Depression in middle-aged and older first generation migrants in Europe: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)M C Aichberger, M Schouler-Ocak, A Mundt, et al.
Open Forum Infectious Diseases|November 22, 2018
Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical TrialsAnirban Basu, Vimalanand S Prabhu, Mary Beth Dorr, et al.
European Journal of Haematology|October 12, 2016
Economic evaluation of chronic lymphocytic leukemia from a hospital management perspectiveFlorian Kron, Nadine Kutsch, Anna Kostenko, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|February 10, 2011
A pilot study of male breast cancer in the Veterans Affairs healthcare systemSacha Satram-Hoang, Edgar M Moran, Hoda Anton-Culver, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 6, 2014
Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in GermanyS M Heimann, M J G T Vehreschild, L Meintker, et al.
The Journal of Hospital Infection|November 14, 2018
Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016S M Heimann, M J G T Vehreschild, O A Cornely, et al.
Blood|August 3, 2006
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependentLuca Gattinoni, Anju Ranganathan, Deborah R Surman, et al.
European Journal of Haematology|October 15, 2014
A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantationSebastian M Heimann, Maria J G T Vehreschild, Oliver A Cornely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile InfectionVimalanand S Prabhu, Oliver A Cornely, Yoav Golan, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 10, 2010
Depression in middle-aged and older first generation migrants in Europe: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)M C Aichberger, M Schouler-Ocak, A Mundt, et al.
Open Forum Infectious Diseases|November 22, 2018
Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical TrialsAnirban Basu, Vimalanand S Prabhu, Mary Beth Dorr, et al.
European Journal of Haematology|October 12, 2016
Economic evaluation of chronic lymphocytic leukemia from a hospital management perspectiveFlorian Kron, Nadine Kutsch, Anna Kostenko, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|February 10, 2011
A pilot study of male breast cancer in the Veterans Affairs healthcare systemSacha Satram-Hoang, Edgar M Moran, Hoda Anton-Culver, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
Pageof 13